Alcohol Alcohol 2010;45(5):449-455
Amgens MariTide Amgens MariTide is capturing the spotlight in the rapidly evolving obesity drug landscape, offering a groundbreaking approach that could rival, and potentially surpass, the efficacy of todays leading therapies
Se suele recetar junto con una dieta hipocalrica y un programa de ejercicio para aumentar su eficacia
GLP-1 (glucagon-like peptide-1) receptor agonists are injectable medications that: Slow digestion to reduce appetite Stimulate insulin production to lower blood sugar Promote weight loss (up to 15% of body weight in some cases) Common brands include: Ozempic (semaglutide) for type 2 diabetes Wegovy (semaglutide) for obesity Mounjaro (tirzepatide) for diabetes and weight loss According to the American Diabetes Association, over 8 million Americans now use GLP-1 drugs-and their foot health impacts are significant
Dietary changes focus on cutting calories while emphasizing high-protein and fiber-rich foods to help maintain muscle and keep you feeling full
If you have a history of severe nausea with semaglutide or tirzepatide, or if you have a BMI under 30, a slower titration may be appropriate